Eli Lilly & Co.

As the landscape of metabolic medicine continues to evolve, the arrival of new therapeutic options for chronic weight management has signaled a shift in how clinicians approach patient care. Among the most notable developments in recent years is the regulatory approval of tirzepatide, a dual-action medication that has redefined treatment paradigms for adults living with … Read more

The medical community is witnessing a significant shift in the approach to chronic weight management, driven by the emergence of dual-agonist medications. At the center of this evolution is tirzepatide, a potent active ingredient that is redefining how clinicians treat obesity and its associated comorbidities on a global scale. As a physician and health journalist, … Read more